Case fatality risk among individuals vaccinated with rVSVΔG-ZEBOV-GP: a retrospective cohort analysis of patients with confirmed Ebola virus disease in the Democratic Republic of the Congo

The rVSVΔG-ZEBOV-GP vaccine constitutes a valuable tool to control Ebola virus disease outbreaks. This retrospective cohort study aimed to assess the protective effect of the vaccine against death among patients with confirmed Ebola virus disease. In this retrospective cohort analysis of patients wi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet infectious diseases 2024-06, Vol.24 (6), p.602-610
Hauptverfasser:	Coulborn, Rebecca M, Bastard, Mathieu, Peyraud, Nicolas, Gignoux, Etienne, Luquero, Francisco, Guai, Bérengère, Bateyi Mustafa, Stephane Hans, Mukamba Musenga, Elisabeth, Ahuka-Mundeke, Steve
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Child Clinical medicine Cohort analysis Death Democratic Republic of the Congo - epidemiology Disease control Ebola Vaccines - administration & dosage Ebola Vaccines - immunology Ebola virus Ebolavirus Ebolavirus - immunology Epidemics Fatalities Female Glycoproteins Health care access Health care facilities Health facilities Health risks Hemorrhagic Fever, Ebola - epidemiology Hemorrhagic Fever, Ebola - mortality Hemorrhagic Fever, Ebola - prevention & control Humans Immunization Infections Laboratories Male Middle Aged Mortality Observational studies Retrospective Studies Risk Factors Translation Vaccination Vaccines Viral diseases Viremia Viruses Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!